A study by Ghatalia et al. (24), which compared intra-patient kinase gene expression between RCC and matched normal kidney samples, identified CHEK2 as one of the top 10 overexpressed kinases in metastatic RCC, suggesting a pathological role of activated CHEK2 in RCC. The gene discussed is CHEK2; the disease is renal cell carcinoma.